{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/CTEV/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-18T15:52:03.116Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":10266,"canonical_name":"Claritev Corp","cik":"0001793229","uei":null,"lei":null,"duns":null,"ticker":"CTEV"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":34},"count":34,"timeline":[{"ts":"2026-10-16","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-10-16","url_slug":"/sec/cik-0001793229/4/0002041258-26-000006","accession_number":"0002041258-26-000006","importance":30},{"ts":"2026-10-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Claritev Corp — 2026-10-15","url_slug":"/sec/cik-0001793229/8-k/0001793229-26-000077","accession_number":"0001793229-26-000077","importance":35},{"ts":"2026-10-15","kind":"sec.filing","form_type":"144","title":"144 — Claritev Corp — 2026-10-15","url_slug":"/sec/cik-0001793229/144/0001950047-26-010268","accession_number":"0001950047-26-010268","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Claritev Corp — 2026-10-01","url_slug":"/sec/cik-0001793229/schedule-13g-a/0001140361-26-038318","accession_number":"0001140361-26-038318","importance":30},{"ts":"2026-09-22","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-09-22","url_slug":"/sec/cik-0001793229/4/0002032799-26-000008","accession_number":"0002032799-26-000008","importance":30},{"ts":"2026-09-21","kind":"sec.filing","form_type":"144","title":"144 — Claritev Corp — 2026-09-21","url_slug":"/sec/cik-0001793229/144/0001950047-26-009699","accession_number":"0001950047-26-009699","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"3","title":"3 — Claritev Corp — 2026-09-16","url_slug":"/sec/cik-0001793229/3/0002153513-26-000006","accession_number":"0002153513-26-000006","importance":30},{"ts":"2026-09-16","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-09-16","url_slug":"/sec/cik-0001793229/4/0002153513-26-000007","accession_number":"0002153513-26-000007","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"8-K","title":"8-K — Claritev Corp — 2026-09-15","url_slug":"/sec/cik-0001793229/8-k/0001793229-26-000071","accession_number":"0001793229-26-000071","importance":35},{"ts":"2026-08-31","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-08-31","url_slug":"/sec/cik-0001793229/4/0001628280-26-059472","accession_number":"0001628280-26-059472","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-08-18","url_slug":"/sec/cik-0001793229/4/0002041258-26-000004","accession_number":"0002041258-26-000004","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"144","title":"144 — Claritev Corp — 2026-08-14","url_slug":"/sec/cik-0001793229/144/0001950047-26-008188","accession_number":"0001950047-26-008188","importance":30},{"ts":"2026-08-12","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-08-12","url_slug":"/sec/cik-0001793229/4/0002033015-26-000006","accession_number":"0002033015-26-000006","importance":30},{"ts":"2026-08-10","kind":"sec.insider.s","reporter":"Mintz William B.","title":"SVP,  Chief Strategy Officer","shares":8431,"price_per_share":34.24,"usd_value":288677,"security_title":"Class A common stock","importance":35.28867744},{"ts":"2026-08-10","kind":"sec.filing","form_type":"144","title":"144 — Claritev Corp — 2026-08-10","url_slug":"/sec/cik-0001793229/144/0001950047-26-007921","accession_number":"0001950047-26-007921","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Claritev Corp — 2026-08-07","url_slug":"/sec/cik-0001793229/10-q/0001793229-26-000067","accession_number":"0001793229-26-000067","importance":45},{"ts":"2026-08-07","kind":"sec.filing","form_type":"8-K","title":"8-K — Claritev Corp — 2026-08-07","url_slug":"/sec/cik-0001793229/8-k/0001793229-26-000065","accession_number":"0001793229-26-000065","importance":35},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-08-07","url_slug":"/sec/cik-0001793229/4/0002032799-26-000006","accession_number":"0002032799-26-000006","importance":30},{"ts":"2026-08-07","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-08-07","url_slug":"/sec/cik-0001793229/4/0002033015-26-000004","accession_number":"0002033015-26-000004","importance":30},{"ts":"2026-08-05","kind":"sec.insider.f","reporter":"Garis Douglas Michael","title":"EVP&CFO","shares":11711,"price_per_share":26.13,"usd_value":306008,"security_title":"Class A common stock","importance":15.30600843},{"ts":"2026-08-05","kind":"sec.insider.f","reporter":"Mintz William B.","title":"SVP,  Chief Strategy Officer","shares":3622,"price_per_share":26.13,"usd_value":94643,"security_title":"Class A common stock","importance":15.09464286},{"ts":"2026-07-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Claritev Corp — 2026-07-06","url_slug":"/sec/cik-0001793229/8-k/0001793229-26-000061","accession_number":"0001793229-26-000061","importance":35},{"ts":"2026-06-30","kind":"sec.insider.a","reporter":"Albinson Brock","title":"SVP, Chief Accounting Officer","shares":3649,"price_per_share":0,"usd_value":0,"security_title":"Class A common stock","importance":15},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — Claritev Corp — 2026-06-22","url_slug":"/sec/cik-0001793229/8-k/0001793229-26-000056","accession_number":"0001793229-26-000056","importance":35},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-06-10","url_slug":"/sec/cik-0001793229/4/0001962112-26-000007","accession_number":"0001962112-26-000007","importance":30},{"ts":"2026-06-09","kind":"sec.insider.p","reporter":"Carol Nutter","title":"SVP, Chief People Officer","shares":875,"price_per_share":28.407,"usd_value":24856,"security_title":"Class A common stock","importance":50.024856125},{"ts":"2026-05-19","kind":"sec.insider.p","reporter":"Prince John Michael","title":null,"shares":10000,"price_per_share":16,"usd_value":160000,"security_title":"Class A common stock","importance":50.16},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-05-19","url_slug":"/sec/cik-0001793229/4/0001828369-26-000014","accession_number":"0001828369-26-000014","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-05-19","url_slug":"/sec/cik-0001793229/4/0001841409-26-000007","accession_number":"0001841409-26-000007","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Claritev Corp — 2026-05-19","url_slug":"/sec/cik-0001793229/4/0001982656-26-000004","accession_number":"0001982656-26-000004","importance":30},{"ts":"2026-05-18","kind":"sec.insider.p","reporter":"Dalton Travis","title":"Pres., CEO & Executive Chair","shares":11200,"price_per_share":11.88,"usd_value":133056,"security_title":"Class A common stock","importance":50.133056},{"ts":"2026-05-18","kind":"sec.insider.p","reporter":"Dalton Travis","title":"Pres., CEO & Executive Chair","shares":9720,"price_per_share":12.92,"usd_value":125582,"security_title":"Class A common stock","importance":50.1255824},{"ts":"2026-05-18","kind":"sec.insider.p","reporter":"Kim Michael","title":"EVP, Chief Digital Officer","shares":3000,"price_per_share":16.65,"usd_value":49950,"security_title":"Class A common stock","importance":50.04995},{"ts":"2026-05-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Claritev Corp — 2026-05-18","url_slug":"/sec/cik-0001793229/8-k/0001793229-26-000052","accession_number":"0001793229-26-000052","importance":35}]}